Clinical Trial Update: Safety Assessment of Intravitreal Mesenchymal Stem Cells for Acute Non Arteritic Anterior Ischemic Optic Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing safety of intravitreal mesenchymal stem cells for acute non-arteritic anterior ischemic optic neuropathy

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-arteritic Ischemic Optic Neuropathy

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA | Conditions: Non Arteritic Ischemic Optic Neuropathy | Phase 2 | Status: UNKNOWN